Last $116.12 USD
Change Today +0.63 / 0.55%
Volume 1.4M
LH On Other Exchanges
New York
As of 8:04 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

358 South Main Street

Burlington, NC 27215

United States

Phone: 336-229-1127


Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company operates a national network of 44 primary laboratories and approximately 1,700 patient service centers (PSCs) along with a network of branches and STAT laboratories (which are laboratories that have the ability to perform certain core tests and report the results to the physician quickly). Laboratory Testing Operations and Services The PSC collects the specimens for testing if requested by the physician. Patient specimens are delivered to the company, accompanied by a test request form (electronic or hard copy). These forms, which are completed by the client or transcribed by a company patient service technician from a client order, indicate the tests to be performed and provide the necessary billing information. Testing Services Core Testing The company offers a range of clinical laboratory tests and procedures. These are used in general patient care by physicians to establish or support a diagnosis, to monitor treatment or medication, or to search for an otherwise undiagnosed condition. The tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, microbiology cultures and procedures and, alcohol and other substance-abuse tests. These core procedures are used by physicians in their outpatient office practices. The company performs this core group of routine tests in each of its primary laboratories. The company performs and reports various routine procedures within 24 hours, utilizing various computerized laboratory testing instruments. Specialty Testing The Specialty Testing Group performs esoteric testing, cancer diagnostics, clinical trials central lab services and other complex procedures.The Specialty Testing Group offers advanced methods and access to scientific expertise in the following disciplines: Anatomic Pathology/Oncology: The company offers advanced comprehensive tumor tissue analysis, including immunohistochemistry (IHC), cancer cytogenetics and fluorescence in situ hybridization (FISH) through its DIANON Pathology (DIANON) and Integrated Oncology specialty testing laboratories. In cancers such as colon and lung cancer, assays such as K-ras, BRAF and EGFR mutation analysis are associated with appropriate therapy choices for a given patient (Pharmacogenomics). Cardiovascular Disease: The company's cardiovascular menu includes core cholesterol tests and expanded lipid profiles, as well as a metabolic syndrome profile and tests for thrombosis and stroke. The company also offers complete testing for monitoring disease progression and response to therapy. Coagulation: The company offers a menu of tests for hemostasis and thrombosis, including bleeding profiles and screening tests, profiles for reproductive health, factor analysis, thrombin generation markers, and thrombotic risk evaluation. Diagnostic Genetics: The company offers cytogenetic, molecular cytogenetic, biochemical and molecular genetic tests. The biochemical genetics offerings include various prenatal screening options, including integrated and sequential prenatal assays for more sensitive assessment of Down Syndrome risk. The company has expanded its cytogenetics offerings through the use of whole genome single-nucleotide polymorphism (SNP) microarray technology, which provides enhanced detection of subtle chromosomal changes associated with the etiology of mental retardation, developmental delay and autism. Endocrinology: The company provides advanced hormone/steroid testing, including comprehensive services for the endocrine specialist. The company additionally offers several endocrine related genetic tests that include CYP21 mutation for congenital adrenal hyperplasia, SHOX gene for short stature, RET mutation for thyroid cancer as well as extensive age and gender-related reference intervals. Infectious Disease: The company provides complete HIV testing services, including viral load measurements, genotyping and phenotyping and host genetic factors that are important tools in managing and treating HIV infections. The addition of resistance tests, P


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LH:US $116.12 USD +0.63

LH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Reference Laboratories Inc $33.63 USD +0.165
Myriad Genetics Inc $38.34 USD +0.55
QIAGEN NV €20.52 EUR -0.04
Quest Diagnostics Inc $71.09 USD +0.52
Sonic Healthcare Ltd A$18.84 AUD -0.01
View Industry Companies

Industry Analysis


Industry Average

Valuation LH Industry Range
Price/Earnings 19.4x
Price/Sales 1.7x
Price/Book 3.5x
Price/Cash Flow 16.2x
TEV/Sales 1.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABORATORY CRP OF AMER HLDGS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at